학술논문

SAR442085, a next generation anti-CD38 antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC) against multiple myeloma
Document Type
Journal
Source
CANCER RESEARCH; AUG 2020, 80 16, 2p. Supplement: S
Subject
Language
English
ISSN
15387445